Northern Trust Corp Spruce Biosciences, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 74,927 shares of SPRB stock, worth $30,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,927

Previous 74,927 -0.0%

Holding current value

$30,720

Previous $38,000 7.89%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.51 - $0.85 $14 - $23	-28 Reduced 0.04%	74,927 $38,000
Q1 2024 May 14, 2024	SELL	$0.7 - $5.49 $15,213 - $119,314	-21,733 Reduced 22.48%	74,955 $59,000
Q4 2023 Feb 13, 2024	BUY	$1.04 - $2.93 $49,944 - $140,710	48,024 Added 98.68%	96,688 $283,000
Q3 2023 Nov 13, 2023	SELL	$2.04 - $2.54 $17,203 - $21,419	-8,433 Reduced 14.77%	48,664 $109,000
Q2 2023 Aug 11, 2023	BUY	$1.92 - $2.6 $83,243 - $112,725	43,356 Added 315.52%	57,097 $122,000
Q1 2023 May 15, 2023	SELL	$1.15 - $3.17 $374 - $1,033	-326 Reduced 2.32%	13,741 $30,000
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.23 $72,473 - $126,262	-56,620 Reduced 80.1%	14,067 $24,000
Q1 2022 May 13, 2022	SELL	$1.85 - $4.59 $7,999 - $19,847	-4,324 Reduced 5.76%	70,687 $143,000
Q4 2021 Feb 08, 2022	BUY	$2.33 - $5.74 $794 - $1,957	341 Added 0.46%	75,011 $334,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $11.26 $19,195 - $35,964	-3,194 Reduced 4.1%	74,670 $449,000
Q2 2021 Aug 13, 2021	BUY	$10.12 - $17.46 $17,406 - $30,031	1,720 Added 2.26%	77,864 $873,000
Q1 2021 May 12, 2021	SELL	$14.8 - $25.79 $45,288 - $78,917	-3,060 Reduced 3.86%	76,144 $1.26 Million
Q4 2020 Feb 11, 2021	BUY	$15.38 - $32.42 $1.22 Million - $2.57 Million	79,204 New	79,204 $1.93 Million

Others Institutions Holding SPRB

# of Institutions

Shares Held

15.4M

Call Options Held

16.7K

Put Options Held

1.1K

View Full List

About SPRUCE BIOSCIENCES, INC.

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.66M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

More about SPRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Spruce Biosciences, Inc. Transaction History